Ambu — Transaction in Own Shares 2016

Aug 19, 2016

Ambu
Ideas that work for life

Share buyback programme

Ambu has decided to purchase up to 268,000 treasury shares in Ambu A/S under a buyback programme, corresponding to a value of approx. DKK 78m at current rate. The share buyback programme is to cover existing share-based incentive schemes and is initiated today on 19 August 2016, ending on 30 September 2016.

The treasury share buyback will be carried out outside the rules set out in Article 5 of the Market Manipulation Directive and according to NASDAQ Copenhagen's guidelines for issuers. The purchases will be carried out at a market price which as a maximum deviates 5% either upwards or downwards compared to the latest price on NASDAQ Copenhagen prior to the purchase and in a way so that the purchases do not influence the actual share price.

Danske Bank will handle the share buyback, and Danske Bank will purchase shares and make trading decisions independently of and without the influence of Ambu within the specified time frame.

The programme is carried out under the authorisation already granted by the annual general assembly, which allows Ambu to acquire treasury shares amounting to up to 10% of the share capital. The acquired shares will therefore be placed in a custody account and treated as a portfolio of treasury shares for accounting purposes. The market price of the treasury shares bought back will be settled in cash.

The treasury share buyback will be carried out in accordance with Ambu's internal insider trading rules and consequently there will be no share buyback within the four weeks closed trading window, which starts four weeks prior to the announcement of Ambu's annual report 2015/16 which is expected on 8 November 2016.

On every seventh trading day at the latest, Ambu will announce the number of shares bought back and their value via a company announcement to NASDAQ Copenhagen. Ambu is entitled to discontinue the programme at any time. Any such decision will be communicated via a company announcement to NASDAQ Copenhagen.

Contact

Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com

About Ambu

Since 1937, breakthrough ideas have driven Ambu's work to bring efficient healthcare solutions to life within our fields of excellence – Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. Millions of patients and healthcare professionals worldwide depend and rely on the functionality and performance of our products. We are dedicated to improving patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu bag and the legendary Blue Sensor® electrodes to our latest landmark solutions such as the aScope™ – the world's first single-use videoscope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognised medtech companies in the world. Our head office is situated in Ballerup near Copenhagen. Ambu has approx. 2,300 employees in Europe, North America, Asia and the Pacific region. You can find more information about Ambu on our website: www.ambu.com.

Ambu

Company announcement no. 35 2015/16
19 August 2016
Page 1 of 1